Ticker: ANVS

Snapshot - Annovis Bio, Inc. (NYSE: ANVS) Quick take: management is advancing a pivotal Phase 3 Alzheimer's trial while burning cash. A successful February 2025 equity raise temporarily rebuilt the balance sheet, but the company still discloses substantial doubt about its ability to continue as a...